Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
Top Cited Papers
- 1 November 2001
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 358 (9294), 1668-1675
- https://doi.org/10.1016/s0140-6736(01)06711-3
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust
- Migraine Trust
This publication has 31 references indexed in Scilit:
- Triptans in MigraineDrugs, 2000
- Guidelines for Controlled Trials of Drugs in Migraine: Second EditionCephalalgia, 2000
- Tolerability of sumatriptan: clinical trials and post-marketing experienceCephalalgia, 2000
- Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy?Headache: The Journal of Head and Face Pain, 1999
- Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo‐Controlled, Outpatient StudyHeadache: The Journal of Head and Face Pain, 1998
- The Mode of Action of Sumatriptan is Vascular? A DebateCephalalgia, 1994
- Oral Sumatriptan: Effect of a Second Dose, and Incidence and Treatment of Headache RecurrencesCephalalgia, 1994
- Methodology of Clinical Trials of Sumatriptan in Migraine and Cluster HeadacheEuropean Neurology, 1991
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Absorption of Effervescent Aspirin during MigraineBMJ, 1974